Phio Pharmaceuticals Reports Q2 2026 Quarterly Financial Results

What Happened Phio Pharmaceuticals Corp. announced its financial results for the quarterly period ended June 30, 2026. The company filed a Current Report on Form 8-K on August 6, 2026 (Accession No. 0001437749-26-026275) and furnished a press release with the results as Exhibit 99.1.

Key Details

• Filing: Form 8-K filed on August 6, 2026 reporting results for the quarter ended June 30, 2026.
• Press release: Financial results were provided via a press release, furnished as Exhibit 99.1 to the 8-K.
• Interactive data: The filing includes the Inline XBRL cover page (Exhibit 104) for machine-readable financial data.
• Item reported: Disclosure was made under Item 2.02 (Results of Operations and Financial Condition).

Why It Matters Earnings and quarterly results give investors current information on the company’s revenue, expenses, and cash position. Phio’s 8-K signals the company has publicly released its latest quarterly performance; investors should read the furnished press release (Exhibit 99.1) for the detailed figures and any management commentary that could affect valuation or near-term outlook. This filing is a routine but material update on the company’s operating and financial condition.